ADMA Biologics Inc (ADMA)
17.41
-0.31
(-1.75%)
USD |
NASDAQ |
Dec 24, 16:00
ADMA Biologics Free Cash Flow: 78.82M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics Inc | 142.60M |
| Alnylam Pharmaceuticals Inc | 16.06M |
| Catalyst Pharmaceuticals Inc | 221.79M |
| Sarepta Therapeutics Inc | -480.40M |
| Krystal Biotech Inc | 58.06M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 25.03M |
| Cash from Investing (Quarterly) | -1.098M |
| Cash from Financing (Quarterly) | -25.47M |
| Free Cash Flow Per Share (Quarterly) | 0.0978 |
| Free Cash Flow to Equity (Quarterly) | 53.68M |
| Free Cash Flow to Firm (Quarterly) | 26.70M |
| Free Cash Flow Yield | 1.91% |